Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention

References

• Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179–c184. doi:10.1159/000339789
   PubMedGoogle Scholar
• Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med. 2019;380(22):2146–2155. doi:10.1056/NEJMra1805256
   PubMed Web of Science ®Google Scholar
• McCullough PA, Choi JP, Feghali GA, et al. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2016;68(13):1465–1473. doi:10.1016/j.jacc.2016.05.099
   PubMed Web of Science ®Google Scholar
• Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936. doi:10.1053/ajkd.2002.32766
   PubMed Web of Science ®Google Scholar
• Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010;362(23):2155–2165. doi:10.1056/NEJMoa0908610
   PubMed Web of Science ®Google Scholar
• Timmis A. Acute coronary syndromes. BMJ. 2015;351:h5153. doi:10.1136/bmj.h5153
   PubMed Web of Science ®Google Scholar
• Chan MY, Sun JL, Newby LK, et al. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation. 2009;119(24):3110–3117. doi:10.1161/CIRCULATIONAHA.108.799981
   PubMed Web of Science ®Google Scholar
• Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z. Risk prediction models for contrast induced nephropathy: systematic review. BMJ. 2015;351:h4395. doi:10.1136/bmj.h4395
   PubMed Web of Science ®Google Scholar
• Allen DW, Ma B, Leung KC, et al. Risk prediction models for contrast-induced acute kidney injury accompanying cardiac catheterization: systematic review and meta-analysis. Can J Cardiol. 2017;33(6):724–736. doi:10.1016/j.cjca.2017.01.018
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399. doi:10.1016/j.jacc.2004.06.068
   PubMed Web of Science ®Google Scholar
• Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793. doi:10.1016/j.jtcvs.2017.12.107
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhang L, Wu Q, et al. Development and validation of a risk nomogram model for predicting revascularization after percutaneous coronary intervention in patients with acute coronary syndrome. Clin Interv Aging. 2021;16:1541–1553. doi:10.2147/CIA.S325385
   PubMed Web of Science ®Google Scholar
• Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1–22. doi:10.18637/jss.v033.i01
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Zwart B, Ten Berg JM, van ’T Hof AW, et al. Indications for an early invasive strategy in NSTE-ACS patients. Neth Heart J. 2020;28(3):131–135. doi:10.1007/s12471-019-01337-5
   PubMed Web of Science ®Google Scholar
• Nijssen EC, Rennenberg RJ, Nelemans PJ, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389(10076):1312–1322. doi:10.1016/S0140-6736(17)30057-0
   PubMed Web of Science ®Google Scholar
• Andreucci M, Solomon R, Tasanarong A. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int. 2014;2014:741018. doi:10.1155/2014/741018
   PubMed Web of Science ®Google Scholar
• Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527–2541. doi:10.1007/s00330-011-2225-0
   PubMed Web of Science ®Google Scholar
• Li M, Tang C, Luo E, Qin Y, Wang D, Yan G. Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-ST elevation acute coronary syndrome. Biomed Res Int. 2020;2020:1860268. doi:10.1155/2020/1860268
   PubMed Web of Science ®Google Scholar
• Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi:10.1186/cc5713
   PubMed Web of Science ®Google Scholar
• Hossain MA, Costanzo E, Cosentino J, et al. Contrast-induced nephropathy: pathophysiology, risk factors, and prevention. Saudi J Kidney Dis Transpl. 2018;29(1):1–9. doi:10.4103/1319-2442.225199
   PubMed Web of Science ®Google Scholar
• Stojanović SD, Fiedler J, Bauersachs J, Thum T, Sedding DG. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis. Eur Heart J. 2020;41(31):2983–2996. doi:10.1093/eurheartj/ehz919
   PubMed Web of Science ®Google Scholar
• Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66(2):286–294. doi:10.1016/j.cardiores.2004.12.027
   PubMed Web of Science ®Google Scholar
• Qin YH, Yan GL, Ma CL, Tang CC, Ma GS. Effects of hyperglycaemia and elevated glycosylated haemoglobin on contrast-induced nephropathy after coronary angiography. Exp Ther Med. 2018;16(1):377–383. doi:10.3892/etm.2018.6183
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45(4):188–195. doi:10.1097/RLI.0b013e3181d2eed8
   PubMed Web of Science ®Google Scholar
• Guo BL, Ouyang FS, Yang SM, et al. Development of a preprocedure nomogram for predicting contrast-induced acute kidney injury after coronary angiography or percutaneous coronary intervention. Oncotarget. 2017;8(43):75087–75093. doi:10.18632/oncotarget.20519
   PubMedGoogle Scholar
• Wang K, Li HL, Bei WJ, et al. Association of left ventricular ejection fraction with contrast-induced nephropathy and mortality following coronary angiography or intervention in patients with heart failure. Ther Clin Risk Manag. 2017;13:887–895. doi:10.2147/TCRM.S137654
   PubMed Web of Science ®Google Scholar
• You Z, Guo T, Lin F, et al. Fibrinogen-to-albumin ratio predicts contrast-induced nephropathy in patients after emergency percutaneous coronary intervention. Cardiol Res Pract. 2019;2019:8260583. doi:10.1155/2019/8260583
   PubMed Web of Science ®Google Scholar
• Çetin M, Erdoğan T, Kırış T, et al. Predictive value of fibrinogen-to-albumin ratio in acute coronary syndrome. Herz. 2020;45(Suppl 1):145–151. doi:10.1007/s00059-019-4840-5
   PubMed Web of Science ®Google Scholar
• Gao F, Zhou YJ, Zhu X, Wang ZJ, Yang SW, Shen H. C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol. 2011;34(3):203–210. doi:10.1159/000329534
   PubMed Web of Science ®Google Scholar
• Asher J, Houston M. Statins and C-reactive protein levels. J Clin Hypertens (Greenwich). 2007;9(8):622–628. doi:10.1111/j.1524-6175.2007.06639.x
   PubMedGoogle Scholar
• Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome). J Am Coll Cardiol. 2014;63(1):71–79. doi:10.1016/j.jacc.2013.04.105
   PubMed Web of Science ®Google Scholar
• Kocas C, Yildiz A, Abaci O, et al. Platelet-to-lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST-segment elevation acute coronary syndrome. Angiology. 2015;66(10):964–968. doi:10.1177/0003319715578057
   PubMed Web of Science ®Google Scholar
• Tziakas D, Chalikias G, Stakos D, et al. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. Am J Cardiol. 2014;113(9):1487–1493. doi:10.1016/j.amjcard.2014.02.004
   PubMed Web of Science ®Google Scholar
• Lei L, Xue Y, Guo Z, et al. Nomogram for contrast-induced acute kidney injury in patients with chronic kidney disease undergoing coronary angiography in China: a cohort study. BMJ Open. 2020;10(5):e037256. doi:10.1136/bmjopen-2020-037256
   PubMed Web of Science ®Google Scholar
• Sidhu RB, Brown JR, Robb JF, et al. Interaction of gender and age on post cardiac catheterization contrast-induced acute kidney injury. Am J Cardiol. 2008;102(11):1482–1486. doi:10.1016/j.amjcard.2008.07.037
   PubMed Web of Science ®Google Scholar
• Liang W, Yu CJ, Wang QY, Yu J. Anemia is associated with increased risk of contrast‑induced acute kidney injury: a systematic review and meta-analysis. Bioengineered. 2021;12(1):648–661. doi:10.1080/21655979.2021.1883887
   PubMed Web of Science ®Google Scholar
• Karamasis GV, Hampton-Till J, Al-Janabi F, et al. Impact of point-of-care pre-procedure creatinine and eGFR testing in patients with ST segment elevation myocardial infarction undergoing primary PCI: the pilot STATCREAT study. Int J Cardiol. 2017;240:8–13. doi:10.1016/j.ijcard.2017.03.147
   PubMed Web of Science ®Google Scholar
• Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol. 2009;192(3):711–718. doi:10.2214/AJR.08.1413
   PubMed Web of Science ®Google Scholar
• Rachoin JS, Wolfe Y, Patel S, Cerceo E. Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem. Ren Fail. 2021;43(1):1311–1321. doi:10.1080/0886022X.2021.1978490
   PubMed Web of Science ®Google Scholar
• Hinson JS, Ehmann MR, Fine DM, et al. Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med. 2017;69:577–586.e4. doi:10.1016/j.annemergmed.2016.11.021
   PubMed Web of Science ®Google Scholar